Detection, verification and significance of differentially expressed miRNAs in bladder urothelial carcinoma

National Medical Journal of China

Volumn 90, Issue 48, 2010, Pages 3391-3394

  Xie, Peng ^a   Xu, Feng ^a   Cheng, Wen ^a   Gao, Jian Ping ^a   Zhang, Zheng Yu ^a   Ge, Jing Ping ^a   Wei, Zhi Feng ^a   Xu, Xiao Feng ^a  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

Bladder neoplasms; MicroRNAs; Reverse transcriptase polymerase chain reaction

Indexed keywords

MICRORNA; MICRORNA 29B; MICRORNA 300; MICRORNA 923; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; BLADDER UROTHELIAL CARCINOMA; CANCER TISSUE; CELL STRAIN; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TRANSITIONAL CELL CARCINOMA; ADULT; BLADDER TUMOR; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUCOSA; PATHOLOGY; UROTHELIUM;

ADULT; CARCINOMA, TRANSITIONAL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MUCOUS MEMBRANE; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84871433382     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.48.002     Document Type: Article

References (11)

1. Fleshner N E, Herr H W, Stewart A K, et al. The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer, 1996, 78: 1505-1513.
2. Ying S Y, Chang D C, Lin S L. The microRNA (miRNA): overview of the RNA genes that modulate gene function. Mol Biotechnol, 2008, 38: 257-268.
3. 2009, 89: 2847-2852.
4. John N E, Cuido S, Jonathan I E, 2006: 96-116.
5. 2010, 27: 407-408.
6. He L, He X, Lowe S W, et al. MicroRNAs join the p53 network - another piece in the tumor-suppression puzzle. Nat Rev Cancer, 2007, 7: 819-822.
7. Gregory P A, Bracken C P, Bert A G, et al. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle, 2008, 7: 3112-3118.
8. Gregory P A, Bert A G, Paterson E L, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biol, 2008, 10: 593-601.
9. Park S M, Gaur A B, Lengyel E, et al. The miR-200 family determines the epithelial phenotype of cancer cells by targenting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev, 2008, 22: 894-907.
10. Korpal M, Lee E S, Hu G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem, 2008, 283: 14910-14914.
11. Ramaswamy S, Ross K N, Lander E S, et al. A molecular signature of metastasis in primary solid tumors. Nature Genet, 2003, 33: 49-54.